258 related articles for article (PubMed ID: 25240975)
21. Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects.
Rajpert-De Meyts E
Hum Reprod Update; 2006; 12(3):303-23. PubMed ID: 16540528
[TBL] [Abstract][Full Text] [Related]
22. From gonocytes to testicular cancer: the role of impaired gonadal development.
Rajpert-de Meyts E; Hoei-Hansen CE
Ann N Y Acad Sci; 2007 Dec; 1120():168-80. PubMed ID: 18184914
[TBL] [Abstract][Full Text] [Related]
23. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
Wünsch L; Holterhus PM; Wessel L; Hiort O
BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
[TBL] [Abstract][Full Text] [Related]
24. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
[TBL] [Abstract][Full Text] [Related]
25. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance.
Looijenga LH; Gillis AJ; Stoop H; Biermann K; Oosterhuis JW
Int J Androl; 2011 Aug; 34(4 Pt 2):e234-51. PubMed ID: 21564133
[TBL] [Abstract][Full Text] [Related]
26. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome.
Schumacher V; Gueler B; Looijenga LH; Becker JU; Amann K; Engers R; Dotsch J; Stoop H; Schulz W; Royer-Pokora B
Mol Reprod Dev; 2008 Sep; 75(9):1484-94. PubMed ID: 18271004
[TBL] [Abstract][Full Text] [Related]
27. Gonadal development and tumor formation at the crossroads of male and female sex determination.
Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
[TBL] [Abstract][Full Text] [Related]
28. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
Pyle LC; Nathanson KL
Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
[TBL] [Abstract][Full Text] [Related]
29. Gonadoblastoma and selected other aspects of gonadal pathology in young patients with disorders of sex development.
Ulbright TM; Young RH
Semin Diagn Pathol; 2014 Sep; 31(5):427-40. PubMed ID: 25129544
[TBL] [Abstract][Full Text] [Related]
30. Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads.
Cools M; Stoop H; Kersemaekers AM; Drop SL; Wolffenbuttel KP; Bourguignon JP; Slowikowska-Hilczer J; Kula K; Faradz SM; Oosterhuis JW; Looijenga LH
J Clin Endocrinol Metab; 2006 Jun; 91(6):2404-13. PubMed ID: 16608895
[TBL] [Abstract][Full Text] [Related]
31. Human testicular (non)seminomatous germ cell tumours: the clinical implications of recent pathobiological insights.
Looijenga LH
J Pathol; 2009 Jun; 218(2):146-62. PubMed ID: 19253916
[TBL] [Abstract][Full Text] [Related]
32. Managing the risk of germ cell tumourigenesis in disorders of sex development patients.
Cools M; Looijenga LH; Wolffenbuttel KP; T'Sjoen G
Endocr Dev; 2014; 27():185-96. PubMed ID: 25247655
[TBL] [Abstract][Full Text] [Related]
33. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia.
Cheng L; Sung MT; Cossu-Rocca P; Jones TD; MacLennan GT; De Jong J; Lopez-Beltran A; Montironi R; Looijenga LH
J Pathol; 2007 Jan; 211(1):1-9. PubMed ID: 17117392
[TBL] [Abstract][Full Text] [Related]
34. [Pathogenesis of neoplastic changes in germ cells as a developmental aspect].
Słowikowska-Hilczer J
Pediatr Endocrinol Diabetes Metab; 2007; 13(1):37-42. PubMed ID: 17493405
[TBL] [Abstract][Full Text] [Related]
35. Germ cell cancer risk in DSD patients.
Cools M
Ann Endocrinol (Paris); 2014 May; 75(2):67-71. PubMed ID: 24786700
[TBL] [Abstract][Full Text] [Related]
36. Seminoma and embryonal carcinoma footprints identified by analysis of integrated genome-wide epigenetic and expression profiles of germ cell cancer cell lines.
van der Zwan YG; Rijlaarsdam MA; Rossello FJ; Notini AJ; de Boer S; Watkins DN; Gillis AJ; Dorssers LC; White SJ; Looijenga LH
PLoS One; 2014; 9(6):e98330. PubMed ID: 24887064
[TBL] [Abstract][Full Text] [Related]
37. Testicular germ cell tumors.
Looijenga LH
Pediatr Endocrinol Rev; 2014 Feb; 11 Suppl 2():251-62. PubMed ID: 24683949
[TBL] [Abstract][Full Text] [Related]
38. Undifferentiated gonadal tissue, Y chromosome instability, and tumors in XY gonadal dysgenesis.
Beaulieu Bergeron M; Lemieux N; Brochu P
Pediatr Dev Pathol; 2011; 14(6):445-59. PubMed ID: 21692598
[TBL] [Abstract][Full Text] [Related]
39. Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development.
Kristensen DM; Sonne SB; Ottesen AM; Perrett RM; Nielsen JE; Almstrup K; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Mol Cell Endocrinol; 2008 Jun; 288(1-2):111-8. PubMed ID: 18420341
[TBL] [Abstract][Full Text] [Related]
40. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
